Skip to main content
S&P 5007,711.39+1.88%DOW53,299.40+2.92%NASDAQ25,908.97+2.12%BTC$80,583.00+3.78%ETH$2,432.70+5.90%GOLD$4,078.50+3.50%OIL$88.26-8.15%
Smart Investors Daily
SID Premium
BM

NASDAQ · BMGL

Basel Medical Group Ltd Ordinary Shares

Healthcare · Medical - Healthcare Plans

$5.21

Up+$0.02 (+0.38%)

Updated Nov 4, 2026, 6:19 PM

SID Score

5.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
13.49M
P/E ratio
0
Dividend yield
0.00%
52-week range
$0.38 – $10.60
Volume
172.62K
Avg. volume
95.27K

Price performance · BMGL

BMGL price history

1M range · 0 trading sessions · Daily adjusted prices

BMGL does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest BMGL news

The latest Smart Investors Daily articles mentioning BMGL.

Stock researchCompany · Overview

BMGL research

Overview

Company profile and research snapshot.

Company profile

Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 9, 2026

Basel Medical Group Ltd (BMGL) Closes Registered Direct Offering

Singapore, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today closed its registered direct offering of 6,000,000 units, raising gross proceeds of US$7.98 million and estimated net proceeds of approximately US$7.28 million. The Company intends to use all of the net proceeds from this offering for general working capital purposes, mergers and acquisitions and other general corporate purposes. As previously announced, the Company entered into a placement

Yahoo · Oct 8, 2026

Basel Medical Group Ltd (BMGL) Prices Registered Direct Offering

Singapore, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today entered into a placement agency agreement with Cathay Securities, Inc., as the placement agent (the “Placement Agent”), as well as a securities purchase agreement with certain purchasers, pursuant to which the Company will issue and sell 6,000,000 units (the “Units”), at a public offering price of US$1.33 per Unit, each consisting of one ordinary share with no par value (each an “Ordinary Sh

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By